Date Range
Date Range
Date Range
Research gaps for improving infectious disease control in animals. Find out more about the diseases. View report for a specific disease. Build report for several diseases. State-of-the-art report on animal health research 2017. One Health and Food Safety. International Conference on Agricultural GHG Emissions and Food Security. XIXth ISAH International Congress on Animal Hygiene. 14th International Congress of the European Association for Veterinary Pharmacology and Toxicology.
eu offer a platform for sharing of available information on isolates of fish pathogens and their sequences to facilitate research on fish pathogens. The databases are free to use, but require subscription. One subscription covers all databases. For terms and conditions for using the database, please see Terms and Conditions. For information on how to use Fishpathogens. eu, please see the F. For more information about what a cookie is, go here.
Conférence annuelle du SIMV le 9 juillet 2015 à Strasbourg. Séminaire du RFSA sur le virus Schmallenberg le 28 janvier 2015. La filière française du médicament vétérinaire au parlement européen. Contribution du RFSA à la mission de Bertrand Hervieu et de Marion Guillou. Conférence du 15 novembre 2012 à Bruxelles.
DFG German-African Cooperation Projects in Infectiology. The project was extended in 2013. The network consists of partner insti.
Wageningen University and Research Centre
Hostmaster FB-IT
Dreijenplein 2
Wageningen, GLD, 6703 HB
NL
Your free hosting account has been activated. You can now use FTP or the file manager in your cPanel to upload your site. Need more power than free hosting? We would recommend using. Would you like to start your own free hosting company? Click here to find out how! .
REWRITING TREATMENT FOR CANCER AND OTHER SERIOUS DISEASES THROUGH EPIGENETIC MEDICINES. Based on clinical proof of concept in treating multiple forms of cancer, our lead product candidate, tazemetostat, is being developed for hematologic malignancies and genetically defined solid tumors. We are also advancing novel compounds directed against a broad range of disease targets.